We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Kate C Robins has been assisting clients through the H1B Visa process since 2020.

As of 2022, Kate C Robins has succesfully submitted and recieved certification for 255 cases.

Kate C Robins is located in Boston, MA, and has represented 10 employers for the H1B Visa Process

260
Cases Handled
255
Cases Certified
98.08%
Approval

Cases Handled by Kate C Robins

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-23067-833069 Certified Medical Scientists Except Epidemiologists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-20352-967494 Certified Medical Scientists Except Epidemiologists Biological Product Except Diagnostic Manufacturing Biogen Inc 2021
I-200-20330-928593 Certified Medical Scientists Except Epidemiologists Biological Product Except Diagnostic Manufacturing Biogen Inc 2021
I-200-20315-906863 Certified - Withdrawn Medical Scientists Except Epidemiologists Biological Product Except Diagnostic Manufacturing Biogen Inc 2021
I-200-20258-821370 Certified Medical Scientists Except Epidemiologists Biological Product Except Diagnostic Manufacturing Biogen Inc 2020
I-200-23249-323548 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics Inc 2023
I-200-23243-311008 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics Inc 2023
I-200-23103-930084 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23103-930054 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023
I-200-23093-899124 Certified Molecular And Cellular Biologists Research And Development In Biotechnology Except Nanobiotechnology Intellia Therapeutics 2023